Back
Alnylam Pharmaceuticals Vs. Simulations Plus Industry Stock Comparison
Buy
55
ALNY
Alnylam Pharmaceuticals
Last Price:
$267.62
Seasonality Move:
25.91%
Sell
36
SLP
Simulations Plus
Last Price:
$30.69
Seasonality Move:
3.81%
Buy
55
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $266.86. The Score for ALNY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
-
The current Simulations Plus [SLP] share price is $31.10. The Score for SLP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SLP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $266.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $31.10The current trend is moderately bearish and SLP is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.93 | Buy |
| Relative Strength Index (14 RSI): | 55.31 | Buy |
| Chaikin Money Flow: | 459021 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (233.87 - 264.49) | Buy |
| Bollinger Bands (100): | (237.56 - 268.76) | Buy |
SLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.26 | Buy |
| Relative Strength Index (14 RSI): | 49.8 | Sell |
| Chaikin Money Flow: | 163733 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.83 - 35.27) | Sell |
| Bollinger Bands (100): | (26.5 - 34.14) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 265.73 | Buy |
| 20-day SMA: | 252.89 | Buy |
| 50-day SMA: | 252.29 | Buy |
| 200-day SMA: | 259.41 | Buy |
| 8-day EMA: | 263.42 | Buy |
| 20-day EMA: | 257.65 | Buy |
| 50-day EMA: | 254.38 | Buy |
| 200-day EMA: | 246.22 | Buy |
SLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.89 | Buy |
| 20-day SMA: | 32.95 | Sell |
| 50-day SMA: | 28.94 | Buy |
| 200-day SMA: | 31.7 | Sell |
| 8-day EMA: | 31.14 | Sell |
| 20-day EMA: | 31.42 | Sell |
| 50-day EMA: | 30.61 | Buy |
| 200-day EMA: | 32.63 | Sell |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.15 per share, an increase next quarter of $1.52 per share, an increase this year of $1.31 per share, and an increase next year of $2.89 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.
Alnylam Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Simulations Plus Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||